Traditional Approaches to Androgen Deprivation TherapyMOUL, Judd W; EVANS, Christopher P; GOMELLA, Leonard G et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 5A, issn 0090-4295, S485-S493, SUPConference Paper

Androgen Deprivation Therapy and Cardiovascular RiskPUNNEN, Sanoj; COOPERBERG, Matthew R; SADETSKY, Natalia et al.Journal of clinical oncology. 2011, Vol 29, Num 26, pp 3510-3516, issn 0732-183X, 7 p.Article

DON'T THINK ONCE, THINK TWICE! THE CARDIOVASCULAR EFFECTS OF ANDROGEN DEPRIVATION THERAPYJEFFERIAES, Edward R; THURAIRAJA, Ramesh; PERSAD, Raj A et al.BJU international (Papier). 2011, Vol 107, Num 7, pp 1023-1028, issn 1464-4096, 6 p.Article

Factors Associated With Reduction in Use of Neoadjuvant Androgen Suppression Therapy Before Radical ProstatectomyO'SHAUGHNESSY, Matthew J; JAROSEK, Stephanie L; VIRNIG, Beth A et al.Urology (Ridgewood, NJ). 2013, Vol 81, Num 4, pp 745-751, issn 0090-4295, 7 p.Article

Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practicePHILLIPS, J. L; WASSERSUG, R. J; MCLEOD, D. L et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 12, pp 1189-1196, issn 1368-5031, 8 p.Article

Weight Gain on Androgen Deprivation Therapy: Which Patients Are at Highest Risk?SEIBLE, Daniel M; XIANGMEI GU; TRINH, Quoc-Dien et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 6, pp 1316-1321, issn 0090-4295, 6 p.Article

Androgen deprivation treatment in prostate cancerTHOMAS, Benjamin C; NEAL, David E.BMJ (Overseas and retired doctors ed.). 2013, Vol 346, Num 7893, pp 34-37, issn 1759-2151, 4 p.Article

Positive surgical margins : The argument for androgen deprivation and chemotherapyHIGANO, Celestia S.Urologic oncology. 2009, Vol 27, Num 1, pp 89-91, issn 1078-1439, 3 p.Conference Paper

Neoadjuvant Androgen Deprivation Therapy Leads to Immediate Impairment of Vitality/ Hormonal and Sexual Quality of Life: Results of a Multicenter Prospective StudyGAY, Hiram Alberto; MICHALSKI, Jeff M; HEMBROFF, Larry et al.Urology (Ridgewood, NJ). 2013, Vol 82, Num 6, pp 1363-1368, issn 0090-4295, 6 p.Article

Androgen deprivation therapy: past, present and futureSCHRÖDER, F; CRAWFORD, E. D; AXCRONA, K et al.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 1-12, issn 1465-5101, 12 p.Conference Paper

Combined Androgen Blockade Revisited : Emerging Options for the Treatment of Castration-Resistant Prostate CancerSIMMONS, Matthew N; KLEIN, Eric A.Urology (Ridgewood, NJ). 2009, Vol 73, Num 4, pp 697-705, issn 0090-4295, 9 p.Article

Role of Androgen Deprivation Therapy for Node-Positive Prostate CancerWONG, Yu-Ning; FREEDLAND, Stephen; EGLESTON, Brian et al.Journal of clinical oncology. 2009, Vol 27, Num 1, pp 100-105, issn 0732-183X, 6 p.Article

Does Timing of Androgen Deprivation Influence Radiation-Induced Toxicity? A Secondary Analysis of Radiation Therapy Oncology Group Protocol 9413TAUSSKY, Daniel; BAE, Kyounghwa; BAHARY, Jean-Paul et al.Urology (Ridgewood, NJ). 2008, Vol 72, Num 5, pp 1125-1129, issn 0090-4295, 5 p.Article

Management of Side Effects of Androgen Deprivation TherapyGROSSMANN, Mathis; ZAJAC, Jeffrey D.Endocrinology and metabolism clinics of North America (Print). 2011, Vol 40, Num 3, issn 0889-8529, ix, 655-671 [18 p.]Article

Sarcopenia During Androgen-Deprivation Therapy for Prostate CancerSMITH, Matthew R; SAAD, Fred; EGERDIE, Blair et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3271-3276, issn 0732-183X, 6 p.Article

SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate CancerMING YANG; WANLING XIE; SHARIFI, Nima et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2565-2573, issn 0732-183X, 9 p.Article

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate CancerD'AMICO, Anthony V; CHEN, Ming-Hui; CROOK, Juanita et al.Journal of clinical oncology. 2011, Vol 29, Num 35, pp 4682-4687, issn 0732-183X, 6 p.Article

Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate CancerKOHLI, Manish; RISKA, Shaun M; CERHAN, James R et al.Mayo Clinic proceedings. 2012, Vol 87, Num 3, pp 240-246, issn 0025-6196, 7 p.Article

New Developments in Prostate Cancer Treatment: Focus on Hormonal Therapy (STOP-3)DE REIJKE, Theo M.BJU international. Supplement (Print). 2012, Vol 109, Num 6, issn 1465-5101, 43 p.Conference Proceedings

Cancer de la prostate, suppression androgénique et pathologies associées = Prostate cancer, androgen deprivation and associated pathologiesCOLOBY, P; DAVIN, J.-L; BOCCON-GIBOD, L et al.Progrès en urologie (Paris). 2012, Vol 22, issn 1166-7087, 66 p., SUP2Serial Issue

Androgen deprivation therapy affects BCL-2 expression in human prostate cancerFUZIO, Paolo; DITONNO, Pasquale; LUCARELLI, Giuseppe et al.International journal of oncology. 2011, Vol 39, Num 5, pp 1233-1242, issn 1019-6439, 10 p.Article

Reimbursement Policy and Androgen-Deprivation Therapy for Prostate CancerSHAHINIAN, Vahakn B; KUO, Yong-Fang; GILBERT, Scott M et al.The New England journal of medicine. 2010, Vol 363, Num 19, pp 1822-1832, issn 0028-4793, 11 p.Article

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?BOLLA, Michel.European urology. Supplement. 2010, Vol 9, Num 11, pp 788-793, issn 1569-9056, 6 p.Article

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerSMITH, Matthew R; EGERDIE, Blair; LEDER, Benjamin Z et al.The New England journal of medicine. 2009, Vol 361, Num 8, pp 745-755, issn 0028-4793, 11 p.Article

The Role of Primary Androgen Deprivation Therapy in Localized Prostate CancerWONG, Yu-Ning; FREEDLAND, Stephen J; EGLESTON, Brian et al.European urology. 2009, Vol 56, Num 4, pp 609-616, issn 0302-2838, 8 p.Article